New discovery in Alzheimer's protein puzzle

By Raquel Maurier

(Medical Xpress) -- A medical research team at the University of Alberta has made two related discoveries that could shed more light on Alzheimer’s disease.

Faculty of Medicine & Dentistry researcher Elena Posse de Chaves and her team recently published their findings in The Journal of Neuroscience.

It has been known for decades that plays an important role in Alzheimer’s . Posse de Chaves’ team discovered that, in brain cells that accumulate toxic levels of the normally occurring beta amyloid , “there is a significant inhibition” in the process that creates brain cholesterol.

Brain cholesterol is vital for normal brain function because it helps protect neurons and helps brain cells fire properly.

What the discovery means is that the relationship between this naturally occurring protein and cholesterol is not just one-way. These findings have been suggested by other research teams as well.

“Our work supports the idea that there is a two-way relationship,” said Posse de Chaves, a researcher in the Department of Pharmacology.

Her team’s work is also important in another area. Those who have Alzheimer’s disease have low levels of a protein known as seladin-1. Some researchers believe this could be an indicator for the disease. This protein is part of the process that leads to the creation of cholesterol. So if cholesterol production is inhibited in Alzheimer’s disease, as demonstrated by the U of A findings, this could explain why levels of the seladin-1 protein are so low.  

“Our findings could explain why that one protein is decreased in the brains of patients with Alzheimer’s disease,” said Posse de Chaves. “This is one piece of the puzzle and every discovery helps.”

According to the Alzheimer Society of Canada, more than 500,000 people in Canada and more than 35 million worldwide have dementia, a group of disorders that includes Alzheimer’s disease.  

The Canadian Institutes of Health Research and the Alzheimer Society of Canada funded the research.

Related Stories

Falls may be early sign of Alzheimer's

Jul 18, 2011

Falls and balance problems may be early indicators of Alzheimer’s disease, researchers at Washington University School of Medicine in St. Louis report July 17, 2011, at the Alzheimer’s Association International ...

Protein that directs cholesterol traffic identified

Feb 20, 2012

(Medical Xpress) -- A protein that directs traffic within human cells has been identified as playing a key role in the accumulation of so-called “bad” cholesterol, according to a new study.

Recommended for you

Lilly, AstraZeneca team up on Alzheimer's drug

Sep 16, 2014

Eli Lilly and Co. plans to pay up to $500 million to fellow drugmaker AstraZeneca as part of a collaboration to develop and sell a potential Alzheimer's disease treatment that is in the early stages of clinical testing.

Report finds scale and cost of dementia escalates

Sep 11, 2014

Dementia UK: The Second Edition, prepared by King's College London and the London School of Economics for the Alzheimer's Society, finds that the cost of dementia to the UK has hit £26 billion a year and ...

User comments